GL1X · GenesisL1 explorer

Research workbench

[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE phosphodiesterase 2 inhibitors

Analyse [1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE phosphodiesterase 2 inhibitors in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6ZND
Type
protein
Length
658 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cgmp-dependent 3',5'-cyclic phosphodiesterase
EC
3.1.4.17
UniProt
O00408
Ligands
QMZ, ZN, MG
Pockets
4 · best druggability 0.84

Structure

x-ray diffraction · 2 distinct chains · 69% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACgmp-dependent 3',5'-cyclic phosphodiesterase (EC 3.1.4.17)protein32467% helix, 0% strandO00408
BCgmp-dependent 3',5'-cyclic phosphodiesterase (EC 3.1.4.17)protein33470% helix, 0% strandO00408

Ligands and binding sites

  • QMZ · [(3~{S})-3-([1,2,4]triazolo[1,5-a]pyrimidin-7-yl) piperidin-1-yl]-(3,4,5-trimethoxyphenyl)methanone · ligand · 2 copies · chains A, B
  • ZN · Zinc ion · metal · 2 copies · chains A, B
  • MG · Magnesium ion · metal · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17650.840.8867MG, QMZ
23500.710.8336MG, QMZ
31770.530.7934empty
41140.510.8118empty

Interfaces

1 interface between chains.

  • A–B · 841 Ų buried · 5 hydrogen bonds · protein-protein

Compared structures

  • 6ZND · [1,2,4]Triazolo[1,5-a]pyrimidine Phosphodiesterase 2 Inhibitors · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.